Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
Digital Health Global
DECEMBER 5, 2023
We are impressed by the unique delivery and editing technologies that Eligo has developed, and we believe this will set the stage for Eligo to forge new paths in the application of in vivo gene-editing technologies.” “We Additionally, it will facilitate Eligo’s expansion into other chronic diseases, including oncology.
Let's personalize your content